In addition, the overall and progression-free survival between PD-L1 positive and PD-L1 negative patients were not different across all of the histological types, and each subtype in particular for serous carcinomas expressing PD-L1 [24]. The gene discussed is CD274; the disease is serous adenocarcinoma.